Title: Systematic literature review on Parkinson's disease and Childhood Leukaemia and mode of actions for pesticides
Abstract: EFSA Supporting PublicationsVolume 13, Issue 1 955E External scientific reportOpen Access Systematic literature review on Parkinson's disease and Childhood Leukaemia and mode of actions for pesticides Judy Choi, Judy Choi BiPRO GmbH, GrauertstrSearch for more papers by this authorAlexandra Polcher, Alexandra Polcher BiPRO GmbH, GrauertstrSearch for more papers by this authorAnke Joas, Anke Joas BiPRO GmbH, GrauertstrSearch for more papers by this author Judy Choi, Judy Choi BiPRO GmbH, GrauertstrSearch for more papers by this authorAlexandra Polcher, Alexandra Polcher BiPRO GmbH, GrauertstrSearch for more papers by this authorAnke Joas, Anke Joas BiPRO GmbH, GrauertstrSearch for more papers by this author First published: 19 January 2016 https://doi.org/10.2903/sp.efsa.2016.EN-955Citations: 7 The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors in the context of a contract between the European Food Safety Authority and the authors, awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. Published date: 19 January 2016 Question number: EFSA-Q-2014-00621 AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References Abdin AA and Hamouda HE, 2008. Mechanism of the Neuroprotective Role of Coenzyme Q10 with or without L-Dopa in Rotenone-Induced Parkinsonism. Neuropharmacology, 55, 1340– 1346. Abu Kar S, Jankowska A, Makishima H, Visconte V, Jerez A, Sugimoto Y, Muramatsu H, Traina F, Afable M, Guinta K, Tiu RV, Przychodzen B, Sakaguchi H, Kojima S, Sekeres MA, List AF, McDevitt MA and Maciejewski JP, 2013. Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia. Haematologica, 98, 107– 113. Agirre X, Roman-Gomez J, Vazquez I, Jimenez-Velasco A, Garate L, Montiel-Duarte C, Artieda P, Cordeu L, Lahortiga I, Calasanz MJ, Heiniger A, Torres A, Minna JD and Prosper F, 2006. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. International Journal of Cancer, 118, 1945– 1953. Ahmadi FA, Linseman DA, Grammatopoulos TN, Jones SM, Bouchard RJ, Freed CR, Heidenreich KA, Zawada WM, 2003. The Pesticide Rotenone Induces Caspase-3-Mediated Apoptosis in Ventral Mesencephalic Dopaminergic Neurons. Journal of Neurochemistry, 87, 914– 921. Airoldi I, Cocco C, Di Carlo E, Disaro S, Ognio E, Basso G and Pistoia V, 2006. Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells. Cancer Research, 66, 3978– 3980. Akundi RS, Hull M, Clement HW, Fiebich BL, 2003. 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) induces apoptosis in human neuroblastoma cell lines. In M. Diederich (Ed.), Apoptosis: From Signaling Pathways to Therapeutic Tools (Vol. 1010, pp. 304– 306). Akundi RS, Macho A, Munoz E, Lieb K, Bringmann G, Clement HW, Hull M, Fiebich BL, 2004. 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH. Journal of Neurochemistry, 91, 263– 273. Al-Quraishy S, Dkhil MA and Moneim AEA, 2012. Protective Effects of Portulaca Oleracea against Rotenone Mediated Depletion of Glutathione in the Striatum of Rats as an Animal Model of Parkinson's Disease. Pesticide Biochemistry and Physiology, 103, 108– 114. Alam M and Schmidt WJ, 2002. Rotenone Destroys Dopaminergic Neurons and Induces Parkinsonian Symptoms in Rats. Behavioural Brain Research, 136, 317– 324. Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, Hussein H, Ishii E, Kamel AM, Labra S, Magalhaes IQ, Mizutani S, Petridou E, de Oliveira MP, Yuen P, Wiemels JL and Greaves MF, 2001. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Research, 61, 2542– 2546. Aleyasin H, Rousseaux MWC, Marcogliese PC, Hewitt SJ, Irrcher I, Joselin AP, Parsanejad M, Kim RH, Rizzu P, Callaghan SM, Slack RS, Mak TW, Park DS, 2010. DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proceedings of the National Academy of Sciences of the United States of America, 107, 3186– 3191. Alvarez-Erviti L, Seow Y, Schapira AHV, Rodriguez-Oroz MC, Obeso JA and Cooper JM, 2013. Influence of Microrna Deregulation on Chaperone-Mediated Autophagy and Alpha-Synuclein Pathology in Parkinson's Disease. Cell Death & Disease, 4. Anderson LR, Betarbet R, Gearing M, Gulcher J, Hicks AA, Stefansson K, Lah JJ, Levey AI, 2007. Park10 Candidate Rnf11 Is Expressed by Vulnerable Neurons and Localizes to Lewy Bodies in Parkinson Disease Brain. Journal of Neuropathology and Experimental Neurology, 66, 955– 964. Andersson AK, Ma J, Wang J, Chen X, Gedman AL, Dang J, Nakitandwe J, Holmfeldt L, Parker M, Easton J, Huether R, Kriwacki R, Rusch M, Wu G, Li Y, Mulder H, Raimondi S, Pounds S, Kang G, Shi L, Becksfort J, Gupta P, Payne-Turner D, Vadodaria B, Boggs K, Yergeau D, Manne J, Song G, Edmonson M, Nagahawatte P, Wei L, Cheng C, Pei D, Sutton R, Venn NC, Chetcuti A, Rush A, Catchpoole D, Heldrup J, Fioretos T, Lu C, Ding L, Pui C-H, Shurtleff S, Mullighan CG, Mardis ER, Wilson RK, Gruber TA, Zhang J, Downing JR and for The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome P, 2015. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nature Genetics, 47, 330– 337. Andreassen OA, Ferrante RJ, Dedeoglu A, Albers DW, Klivenyi P, Carlson EJ, Epstein CJ, Beal MF, 2001. Mice with a Partial Deficiency of Manganese Superoxide Dismutase Show Increased Vulnerability to the Mitochondrial Toxins Malonate, 3-Nitropropionic Acid, and Mptp. Experimental Neurology, 167, 189– 195. Antkiewicz-Michaluk L, 2002. Endogenous Risk Factors in Parkinson's Disease: Dopamine and Tetrahydroisoquinolines. Polish Journal of Pharmacology, 54, 567– 572. Antkiewicz-Michaluk L, Karolewicz B, Romanska I, Michaluk J, Bojarski AJ and Vetulani J, 2003. 1-Methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain. European Journal of Pharmacology, 466, 263– 269. Antkiewicz-Michaluk L, Romanska I, Papla I, Michaluk J, Bakalarz M, Vetulani J, Krygowska-Wajs A and Szczudlik A, 2000. Neurochemical Changes Induced by Acute and Chronic Administration of 1,2,3,4-Tetrahydroisoquinoline and Salsolinol in Dopaminergic Structures of Rat Brain. Neuroscience, 96, 59– 64. Antkiewicz-Michaluk L, Wardas J, Michaluk J, Romanska I, Bojarski A and Vetulani J, 2004. Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone. International Journal of Neuropsychopharmacology, 7, 155– 163. Aplan PD, 2006a. Causes of oncogenic chromosomal translocation. Trends in Genetics, 22, 46– 55. Aplan PD, 2006b. Chromosomal translocations involving the MLL gene: Molecular mechanisms. DNA Repair, 5, 1265– 1272. Aranaz P, Hurtado C, Erquiaga I, Migueliz I, Ormazabal C, Cristobal I, Garcia-Delgado M, Javier Novo F and Luis Vizmanos J, 2012. CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2. Haematologica-the Hematology Journal, 97, 1234– 1241. Arawaka S, Wada M, Goto S, Karube H, Sakamoto M, Ren C-H, Koyama S, Nagasawa H, Kimura H, Kawanami T, Kurita K, Tajima K, Daimon M, Baba M, Kido T, Saino S, Goto K, Asao H, Kitanaka C, Takashita E, Hongo S, Nakamura T, Kayama T, Suzuki Y, Kobayashi K, Katagiri T, Kurokawa K, Kurimura M, Toyoshima I, Niizato K, Tsuchiya K, Iwatsubo T, Muramatsu M, Matsumine H and Kato T, 2006. The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease. Journal of Neuroscience, 26, 9227– 9238. Arduino DM, Esteves AR, Cardoso SM, 2013. Mitochondria Drive Autophagy Pathology Via Microtubule Disassembly a New Hypothesis for Parkinson Disease. Autophagy, 9, 112– 114. Arduino DM, Esteves AR, Cardoso SM, Oliveira CR, 2009. Endoplasmic Reticulum and Mitochondria Interplay Mediates Apoptotic Cell Death: Relevance to Parkinson's Disease. Neurochemistry International, 55, 341– 348. Arduino DM, Raquel Esteves A and Cardoso SM, 2011. Mitochondrial Fusion/Fission, Transport and Autophagy in Parkinson's Disease: When Mitochondria Get Nasty. Parkinsons Disease. Arif M, Kazim SF, Grundke-Iqbal I, Garruto RM and Iqbal K, 2014. Tau Pathology Involves Protein Phosphatase 2a in Parkinsonism-Dementia of Guam. Proceedings of the National Academy of Sciences of the United States of America, 111, 1144– 1149. Arimoto T, Choi D-Y, Lu X, Liu M, Nguyen XV, Zheng N, Stewart CA, Kim H-C and Bing G, 2007. Interleukin-10 Protects against Inflammation-Mediated Degeneration of Dopaminergic Neurons in Substantia Nigra. Neurobiology of Aging, 28, 894– 906. Armstrong SA and Look AT, 2005. Molecular genetics of acute lymphoblastic leukemia. Journal of Clinical Oncology, 23, 6306– 6315. Arnold B, Cassady SJ, VanLaar VS, Berman SB, 2011. Integrating Multiple Aspects of Mitochondrial Dynamics in Neurons: Age-Related Differences and Dynamic Changes in a Chronic Rotenone Model. Neurobiology of Disease, 41, 189– 200. Arranz AM, Delbroek L, Van Kolen K, Guimaraes MR, Mandemakers W, Daneels G, Matta S, Calafate S, Shaban H, Baatsen P, De Bock PJ, Gevaert K, Vanden Berghe P, Verstreken P, De Strooper B and Moechars D, 2014. Lrrk2 Functions in Synaptic Vesicle Endocytosis through a Kinase-Dependent Mechanism. J Cell Sci. Aschner M, Guilarte TR, Schneider JS, Zheng W, 2007. Manganese: Recent Advances in Understanding Its Transport and Neurotoxicity. Toxicology and Applied Pharmacology, 221, 131– 147. Assous M, Had-Aissouni L, Gubellini P, Melon C, Nafia I, Salin P, Kerkerian-Le-Goff L and Kachidian P, 2014. Progressive Parkinsonism by Acute Dysfunction of Excitatory Amino Acid Transporters in the Rat Substantia Nigra. Neurobiology of Disease, 65, 69– 81. Astolfi A, Vendemini F, Urbini M, Melchionda F, Masetti R, Franzoni M, Libri V, Serravalle S, Togni M, Paone G, Montemurro L, Bressanin D, Chiarini F, Martelli AM, Tonelli R, Pession A, 2014. MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia. Oncotarget, 5, 120– 130. Ayton S and Lei P, 2014. Nigral Iron Elevation Is an Invariable Feature of Parkinson's Disease and Is a Sufficient Cause of Neurodegeneration. Biomed Research International. Ayton S, Lei P, Adlard PA, Volitakis I, Cherny RA, Bush AI, Finkelstein DI, 2014. Iron Accumulation Confers Neurotoxicity to a Vulnerable Population of Nigral Neurons: Implications for Parkinson's Disease. Molecular Neurodegeneration, 9. Azarova AM, Lin R-K, Tsai Y-C, Liu LF, Lin C-P and Lyu YL, 2010. Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia. Biochemical and Biophysical Research Communications, 399, 66– 71. Aznavour N, Cendres-Bozzi C, Lemoine L, Buda C, Sastre J-P, Mincheva Z, Zimmer L and Lin J-S, 2012. MPTP animal model of Parkinsonism: dopamine cell death or only tyrosine hydroxylase impairment? A study using PET imaging, autoradiography, and immunohistochemistry in the cat. CNS Neuroscience & Therapeutics, 18, 934– 941. Ba XH, 2014. Therapeutic Effects of Gm1 on Parkinson's Disease in Rats and Its Mechanism. Int J Neurosci, 1– 17. Baccichet A, Benachenhou N, Couture F, Leclerc JM, Sinnett D, 1997. Microsatellite instability in childhood T cell acute lymphoblastic leukemia. Leukemia, 11, 797– 802. Bachmann PS, Piazza RG, Janes ME, Wong NC, Davies C, Mogavero A, Bhadri VA, Szymanska B, Geninson G, Magistroni V, Cazzaniga G, Biondi A, Miranda-Saavedra D, Goettgens B, Saffery R, Craig JM, Marshall GM, Gambacorti-Passerini C, Pimanda JE and Lock RB, 2010. Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition. Blood, 116, 3013– 3022. Badham HJ, LeBrun DP, Rutter A, Winn LM, 2010. Transplacental benzene exposure increases tumor incidence in mouse offspring: possible role of fetal benzene metabolism. Carcinogenesis, 31, 1142– 1148. Badham HJ and Winn LM, 2007. Investigating the role of the aryl hydrocarbon receptor in benzene-initiated toxicity in vitro. Toxicology, 229, 177– 185. Badham HJ and Winn LM, 2010a. In utero and in vitro effects of benzene and its metabolites on erythroid differentiation and the role of reactive oxygen species. Toxicology and Applied Pharmacology, 244, 273– 279. Badham HJ and Winn LM, 2010b. In Utero Exposure to Benzene Disrupts Fetal Hematopoietic Progenitor Cell Growth via Reactive Oxygen Species. Toxicological Sciences, 113, 207– 215. Bae E-J, Yang N-Y, Song M, Lee CS, Lee JS, Jung BC, Lee H-J, Kim S, Masliah E, Sardi SP and Lee S-J, 2014a. Glucocerebrosidase Depletion Enhances Cell-to-Cell Transmission of Alpha-Synuclein. Nature Communications, 5. Bae EJ, Lee C, Lee HJ, Kim S, Lee SJ, 2014b. Atp13a2/Park9 Deficiency Neither Cause Lysosomal Impairment nor Alter Alpha-Synuclein Metabolism in Sh-Sy5y Cells. Exp Neurobiol, 23, 365– 371. Bae JH, Jang BC, Suh SI, Ha E, Baik HH, Kim SS, Lee MY, Shin DH, 2006. Manganese Induces Inducible Nitric Oxide Synthase (Inos) Expression Via Activation of Both Map Kinase and Pi3k/Akt Pathways in Bv2 Microglial Cells. Neuroscience Letters, 398, 151– 154. Bailey HD, Armstrong BK, de Klerk NH, Fritschi L, Attia J, Scott RJ, Smibert E, Milne E and Aus ALLC, 2011. Exposure to professional pest control treatments and the risk of childhood acute lymphoblastic leukemia. International Journal of Cancer, 129, 1678– 1688. Bailey HD, Fritschi L, Infante-Rivard C, Glass DC, Miligi L, Dockerty JD, Lightfoot T, Clavel J, Roman E, Spector LG, Kaatsch P, Metayer C, Magnani C, Milne E, Polychronopoulou S, Simpson J, Rudant J, Sidi V, Rondelli R, Orsi L, Kang AY, Petridou E and Schuez J, 2014. Parental occupational pesticide exposure and the risk of childhood leukemia in the offspring: Findings from the childhood leukemia international consortium. International Journal of Cancer, 135, 2157– 2172. Bailey HD, Infante-Rivard C, Metayer C, Clavel J, Lightfoot T, Kaatsch P, Roman E, Magnani C, Spector LG, Petridou E, Milne E, Dockerty JD, Miligi L, Armstrong BK, Rudant J, Fritschi L, Simpson J, Zhang L, Rondelli R, Baka M, Orsi L, Moschovi M, Kang AY and Schuz J, 2015. Home pesticide exposures and risk of childhood leukemia: Findings from the Childhood Leukemia International Consortium. International Journal of Cancer. Baker RK, Kurz EU, Pyatt DW, Irons RD, Kroll DJ, 2001. Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase II alpha. Blood, 98, 830– 833. Balgobind BV, Van Vlierberghe P, van den Ouweland AMW, Beverloo HB, Terlouw-Kromosoeto JNR, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJL, Pieters R, Zwaan CM, Van den Heuvel-Eibrink MM and Meijerink JPP, 2008. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood, 111, 4322– 4328. Ballerini P, Blaise A, Coniat MBL, Su XY, Zucman-Rossi J, Adam M, van den Akker J, Perot C, Pellegrino B, Landman-Parker J, Douay L, Berger R and Bernard OA, 2002. HOX11L2 expression, defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood, 100, 991– 997. Bandele OJ, Clawson SJ, Osheroff N, 2008. Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement. Chemical Research in Toxicology, 21, 1253– 1260. Bandele OJ and Osheroff N, 2007. Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry, 46, 6097– 6108. Bandele OJ and Osheroff N, 2008. The Efficacy of Topoisomerase II-Targeted Anticancer Agents Reflects the Persistence of Drug-Induced Cleavage Complexes in Cells. Biochemistry, 47, 11900– 11908. Bandopadhyay R, Kingsbury AE, Muqit MM, Harvey K, Reid AR, Kilford L, Engelender S, Schlossmacher MG, Wood NW, Latchman DS, Harvey RJ, Lees AJ, 2005. Synphilin-1 and Parkin Show Overlapping Expression Patterns in Human Brain and Form Aggresomes in Response to Proteasomal Inhibition. Neurobiology of Disease, 20, 401– 411. Banerjee K, Munshi S, Sen O, Pramanik V, Mukherjee TR, Chakrabarti S, 2014. Dopamine Cytotoxicity Involves Both Oxidative and Nonoxidative Pathways in Sh-Sy5y Cells: Potential Role of Alpha-Synuclein Overexpression and Proteasomal Inhibition in the Etiopathogenesis of Parkinson's Disease. Parkinsons Disease. Barallobre MJ, Perier C, Bove J, Laguna A, Delabar JM, Vila M, Arbones ML, 2014. Dyrkla Promotes Dopaminergic Neuron Survival in the Developing Brain and in a Mouse Model of Parkinson's Disease. Cell Death & Disease, 5. Baranyi M, Milusheva E, Vizi ES, Sperlagh B, 2006. Chromatographic Analysis of Dopamine Metabolism in a Parkinsonian Model. Journal of Chromatography A, 1120, 13– 20. Barbanti P, Fabbrini G, Ricci A, Cerbo R, Bronzetti E, Caronti B, Calderaro C, Felici L, Stocchi F, Meco G, Amenta F, Lenzi GL, 1999. Increased Expression of Dopamine Receptors on Lymphocytes in Parkinson's Disease. Movement Disorders, 14, 764– 771. Barcia-Gonzalez C and Herrero-Ezquerro MT, 2004. Inflammation and Parkinson's Disease. Revista De Neurologia, 38, 545– 553. Bardini M, Galbiati M, Lettieri A, Bungaro S, Gorletta TA, Biondi A, Cazzaniga G, 2011. Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients. Leukemia, 25, 175– 178. Bardini M, Spinelli R, Bungaro S, Mangano E, Corral L, Cifola I, Fazio G, Giordan M, Basso G, De Rossi G, Biondi A, Battaglia C and Cazzaniga G, 2010. DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4. Leukemia, 24, 169– 176. Barkats M, Millecamps S, Bilang-Bleuel A and Mallet J, 2002. Neuronal Transfer of the Human Cu/Zn Superoxide Dismutase Gene Increases the Resistance of Dopaminergic Neurons to 6-Hydroxydopamine. Journal of Neurochemistry, 82, 101– 109. Barroso N, Campos Y, Huertas R, Esteban J, Molina JA, Alonso A, Gutierrezrivas E, Arenas J, 1993. Respiratory-Chain Enzyme-Activities in Lymphocytes from Untreated Patients with Parkinson Disease. Clinical Chemistry, 39, 667– 669. Bartels T, Choi JG, Selkoe DJ, 2011. Alpha-Synuclein Occurs Physiologically as a Helically Folded Tetramer That Resists Aggregation. Nature, 477, 107– U123. Bash RO, Hall S, Timmons CF, Crist WM, Amylon M, Smith RG, Baer R, 1995. Does activation of the Tal1 gene occur in a majority of patients with T-cell acute Lymphoblastic leukemia - A pediatric-oncology-group study. Blood, 86, 666– 676. Bashkatova V, Alam M, Vanin A, Schmidt WJ, 2004. Chronic Administration of Rotenone Increases Levels of Nitric Oxide and Lipid Peroxidation Products in Rat Brain. Experimental Neurology, 186, 235– 241. Basso E, Antas P, Marijanovic Z, Goncalves S, Tenreiro S, Outeiro TF, 2013. Plk2 Modulates Alpha-Synuclein Aggregation in Yeast and Mammalian Cells. Molecular Neurobiology, 48, 854– 862. Bate C, Gentleman S, Williams A, 2010. Alpha-Synuclein Induced Synapse Damage Is Enhanced by Amyloid-Beta(1-42). Molecular Neurodegeneration, 5. Batelli S, Albani D, Rametta R, Polito L, Prato F, Pesaresi M, Negro A, Forloni G, 2008. Dj-1 Modulates Alpha-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of Hsp70. Plos One, 3. Batlevi Y and La Spada AR, 2011. Mitochondrial Autophagy in Neural Function, Neurodegenerative Disease, Neuron Cell Death, and Aging. Neurobiology of Disease, 43, 46– 51. Baysal BE, 2007. A Recurrent Stop-Codon Mutation in Succinate Dehydrogenase Subunit B Gene in Normal Peripheral Blood and Childhood T-Cell Acute Leukemia. PLoS One, 2. Beal MF, 1998. Excitotoxicity and Nitric Oxide in Parkinson's Disease Pathogenesis. Annals of Neurology, 44, S110– S114 Beaupre DM, Talpaz M, Marini FC, Cristiano RJ, Roth JA, Estrov Z, Albitar M, Freedman MH, Kurzrock R, 1999. Autocrine interleukin-1 beta production in leukemia: Evidence for the involvement of mutated RAS. Cancer Research, 59, 2971– 2980. Beavan MS and Schapira AHV, 2013. Glucocerebrosidase Mutations and the Pathogenesis of Parkinson Disease. Annals of Medicine, 45, 511– 521. Beccano-Kelly DA, Kuhlmann N, Tatamikov I, Volta M, Munsie LN, Chou P, Cao L-P, Han H, Tapia L, Farrer MJ and Milnerwood AJ, 2014. Synaptic Function Is Modulated by Lrrk2 and Glutamate Release Is Increased in Cortical Neurons of G2019s Lrrk2 Knock-in Mice. Frontiers in Cellular Neuroscience, 8. Bedard C, Wallman M-J, Pourcher E, Gould PV, Parent A and Parent M, 2011. Serotonin and Dopamine Striatal Innervation in Parkinson's Disease and Huntington's Chorea. Parkinsonism & Related Disorders, 17, 593– 598. Behrouz B, Vilarino-Guell C, Heckman MG, Soto-Ortolaza AI, Aasly JO, Sando S, Lynch T, Craig D, Uitti RJ, Wszolek ZK, Ross OA and Farrer MJ, 2010. Mitochondrial Translation Initiation Factor 3 Polymorphism and Parkinson's Disease. Neuroscience Letters, 486, 228– 230. Belcastro V, Tozzi A, Tantucci M, Costa C, Filippo MD, Autuori A, Picconi B, Siliquini S, Luchetti E, Borsini F, Calabresi P, 2009. A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity. Experimental Neurology, 217, 231– 234. Bellucci A, Navarria L, Falarti E, Zaltieri M, Bono F, Collo G, Grazia M, Missale C, Spano P, 2011. Redistribution of Dat/Alpha-Synuclein Complexes Visualized by "in Situ" Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's Disease. Plos One, 6. Bellucci A, Zaltieri M, Navarria L, Grigoletto J, Missale C, Spano P, 2012. From Alpha-Synuclein to Synaptic Dysfunctions: New Insights into the Pathophysiology of Parkinson's Disease. Brain Research, 1476, 183– 202. Belluzzi E, Bisaglia M, Lazzarini E, Tabares LC, Beltramini M, Bubacco L, 2012. Human Sod2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson's Disease. Plos One, 7. Benshachar D, Riederer P, Youdim MBH, 1991. Iron Melanin Interaction and Lipid-Peroxidation -Implications for Parkinson's Disease. Journal of Neurochemistry, 57, 1609– 1614. Beraud D, Hathaway HA, Trecki J, Chasovskikh S, Johnson DA, Johnson JA, Federoff HJ, Shimoji M, Mhyre TR and Maguire-Zeiss KA, 2013. Microglial Activation and Antioxidant Responses Induced by the Parkinson's Disease Protein Alpha-Synuclein. Journal of Neuroimmune Pharmacology, 8, 94– 117. Bergeron M, Motter R, Tanaka P, Fauss D, Babcock M, Chiou SS, Nelson S, San Pablo F and Anderson JP, 2014. In Vivo Modulation of Polo-Like Kinases Supports a Key Role for Plk2 in Ser129 Alpha-Synuclein Phosphorylation in Mouse Brain. Neuroscience, 256, 72– 82. Bernauer U, Vieth B, Ellrich R, Heinrich-Hirsch B, Janig GR and Gundert-Remy U, 1999. CYP2E1-dependent benzene toxicity: the role of extrahepatic benzene metabolism. Archives of Toxicology, 73, 189– 196. Bernstein AI, Garrison SP, Zambetti GP and O'Malley KL, 2011. 6-Ohda Generated Ros Induces DNA Damage and P53-and Puma-Dependent Cell Death. Molecular Neurodegeneration, 6. Berry C, La Vecchia C and Nicotera P, 2010. Paraquat and Parkinson's Disease. Cell Death and Differentiation, 17, 1115– 1125. Bertoncini CW, Jung YS, Fernandez CO, Hoyer W, Griesinger C, Jovin TM, Zweckstetter M, 2005. Release of Long-Range Tertiary Interactions Potentiates Aggregation of Natively Unstructured Alpha-Synuclein. Proceedings of the National Academy of Sciences of the United States of America, 102, 1430– 1435. Betarbet R, Canet-Aviles RA, Sherer TB, Mastroberardino PG, McLendon C, Kim JH, Lund S, Na HM, Taylor G, Bence NF, Kopito R, Seo BB, Yagi T, Klinefelter G, Cookson MR and Greenamyre JT, 2006. Intersecting Pathways to Neurodegeneration in Parkinson's Disease: Effects of the Pesticide Rotenone on Dj-1, Alpha-Synuclein, and the Ubiquitin-Proteasome System. Neurobiology of Disease, 22, 404– 420. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV and Greenamyre JT, 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature Neuroscience, 3, 1301– 1306. Bezard E, Gross CE, Fournier MC, Dovero S, Bloch B, Jaber M, 1999. Absence of Mptp-Induced Neuronal Death in Mice Lacking the Dopamine Transporter. Experimental Neurology, 155, 268– 273. Bhatt MH, Elias MA, Mankodi AK, 1999. Acute and reversible parkinsonism due to organophosphate pesticide intoxication - Five cases. Neurology, 52, 1467– 1471. Bick RJ, Poindexter BJ, Kott MM, Liang YA, Dinh K, Kaur B, Bick DLM, Doursout M-F and Schiess MC, 2008. Cytokines Disrupt Intracellular Patterns of Parkinson's Disease-Associated Proteins Alpha-Synuclein, Tau and Ubiquitin in Cultured Glial Cells. Brain Research, 1217, 203– 212. Biondi A, Cimino G, Pieters R, Pui CH, 2000. Biological and therapeutic aspects of infant leukemia. Blood, 96, 24– 33. Biondi A and Masera G, 1998. Molecular pathogenesis of childhood acute lymphoblastic leukemia. Haematologica, 83, 651– 659. Bir A, Sen O, Anand S, Khemka VK, Banerjee P, Cappai R, Sahoo A, Chakrabarti S, 2014. Alpha-Synuclein-Induced Mitochondrial Dysfunction in Isolated Preparation and Intact Cells: Implications in the Pathogenesis of Parkinson's Disease. Journal of Neurochemistry, 131, 868877. Birtwistle L, Hayden RE, Khanim FL, Green RM, Pearce C, Davies NJ, Wake N, Schrewe H, Ride JP, Chipman JK, Bunce CM, 2009. The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 662, 67– 74. Bisaglia M, Soriano ME, Arduini I, Mammi S, Bubacco L, 2010. Molecular Characterization of Dopamine-Derived Quinones Reactivity toward Nadh and Glutathione: Implications for Mitochondrial Dysfunction in Parkinson Disease. Biochimica Et Biophysica Acta-Molecular Basis of Disease, 1802, 699– 706. Bjorkblom B, Adilbayeva A, Maple-Grodem J, Piston D, Okvist M, Xu XM, Brede C, Larsen JP and Moller SG, 2013. Parkinson Disease Protein Dj-1 Binds Metals and Protects against Metal-Induced Cytotoxicity. Journal of Biological Chemistry, 288, 22809– 22820. Blackinton J, Kumaran R, van der Brug MP, Ahmad R, Olson L, Galter D, Lees A, Bandopadhyay R and Cookson MR, 2009. Post-Transcriptional Regulation of Mrna Associated with Dj-1 in Sporadic Parkinson Disease. Neuroscience Letters, 452, 8– 11. Blanco JG, Edick MJ, Relling MV, 2004. Etoposide induces chimeric Mll gene fusions. Faseb Journal, 18, 173– 175. Blandini F, Cosentino M, Mangiagalli A, Marino F, Samuele A, Rasini E, Fancellu R, Tassorelli C, Pacchetti C, Martignoni E, Riboldazzi G, Calandrella D, Lecchini S, Frigo G, Nappi G, 2004. Modifications of Apoptosis-Related Protein Levels in Lymphocytes of Patients with Parkinson's Disease. The Effect of Dopaminergic Treatment. Journal of Neural Transmission, 111, 1017– 1030. Blandini F, Levandis